Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Clinical trial NCT04681911 · UNKNOWN
Trial details
- NCT number
- NCT04681911
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2023-09-09
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.